Myriam Cuadrado

Myriam Cuadrado

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2007 in Journal of Cell Biology
Verified
Journal Article
Open access
MMMatilde Murga
Matilde Murga
IJIsabel Jaco
Isabel Jaco
YFYuhong Fan
Yuhong Fan
RSRebeca Soria
Rebeca Soria
BMBarbara Martinez-Pastor
Barbara Martinez-Pastor
OFOscar Fernandez-Capetillo
Oscar Fernandez-Capetillo
In response to DNA damage, chromatin undergoes a global decondensation process that has been proposed to facilitate genome surveillance. However, the impact that chromatin compaction has on the DNA damage response (DDR) has not directly been tested and thus remains speculative. We apply two independent approaches (one based on murine embryonic stem cells with reduced amounts of the linker histone H1 and the second making use of histone deacetylase inhibitors) to show that the strength of the DDR is amplified in the context of “open” chromatin. H1-depleted cells are hyperresistant to DNA damage and present hypersensitive checkpoints, phenotypes that we show are explained by an increase in the amount of signaling generated at each DNA break. Furthermore, the decrease in H1 leads to a general increase in telomere length, an as of yet unrecognized role for H1 in the regulation of chromosome structure. We propose that slight differences in the epigenetic configuration might account for the cell-to-cell variation in the strength of the DDR observed when groups of cells are challenged with DNA breaks.

6 February 2006 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MCMyriam Cuadrado
Myriam Cuadrado
BMBarbara Martinez-Pastor
Barbara Martinez-Pastor
MMMatilde Murga
Matilde Murga
LTLuis Toledo
Luis Toledo
PGPaula Gutierrez-Martinez
Paula Gutierrez-Martinez
OFOscar Fernandez-Capetillo
Oscar Fernandez-Capetillo
DNA double-strand breaks (DSBs) are among the most deleterious lesions that can challenge genomic integrity. Concomitant to the repair of the breaks, a rapid signaling cascade must be coordinated at the lesion site that leads to the activation of cell cycle checkpoints and/or apoptosis. In this context, ataxia telangiectasia mutated (ATM) and ATM and Rad-3–related (ATR) protein kinases are the earliest signaling molecules that are known to initiate the transduction cascade at damage sites. The current model places ATM and ATR in separate molecular routes that orchestrate distinct pathways of the checkpoint responses. Whereas ATM signals DSBs arising from ionizing radiation (IR) through a Chk2-dependent pathway, ATR is activated in a variety of replication-linked DSBs and leads to activation of the checkpoints in a Chk1 kinase–dependent manner. However, activation of the G2/M checkpoint in response to IR escapes this accepted paradigm because it is dependent on both ATM and ATR but independent of Chk2. Our data provides an explanation for this observation and places ATM activity upstream of ATR recruitment to IR-damaged chromatin. These data provide experimental evidence of an active cross talk between ATM and ATR signaling pathways in response to DNA damage.

11 November 2009 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MCMyriam Cuadrado
Myriam Cuadrado
PGPaula Gutierrez-Martinez
Paula Gutierrez-Martinez
ASAneta Swat
Aneta Swat
ANAngel R. Nebreda
Angel R. Nebreda
OFOscar Fernandez-Capetillo
Oscar Fernandez-Capetillo
One of the current models of cancer proposes that oncogenes activate a DNA damage response (DDR), which would limit the growth of the tumor in its earliest stages. In this context, and in contrast to studies focused on the acute responses to a one-time genotoxic insult, understanding how cells respond to a persistent source of DNA damage might become critical for future studies in the field. We here report the discovery of a novel damage-responsive pathway, which involves p27Kip1 and retinoblastoma tumor suppressors and is only implemented after a persistent exposure to clastogens. In agreement with its late activation, we show that this pathway is critical for the maintenance, but not the initiation, of the cell cycle arrest triggered by DNA damage. Interestingly, this late response is independent of the canonical ataxia telangiectasia mutated–dependent and ataxia telangiectasia mutated and Rad3-related–dependent DDR but downstream of p38 mitogen-activated protein kinase. Our results might help to reconcile the oncogene-induced DNA damage model with the clinical evidence that points to non-DDR members as the most important tumor suppressors in human cancer. [Cancer Res 2009;69(22):8726–32]

22 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
LLL. Francisco Lorenzo-Martín
L. Francisco Lorenzo-Martín
NFNatalia Fernández-Parejo
Natalia Fernández-Parejo
MMMauricio Menacho-Márquez
Mauricio Menacho-Márquez
SRSonia Rodríguez-Fdez
Sonia Rodríguez-Fdez
Javier Robles ValeroJavier Robles Valero
Javier Robles Valero
Xosé BusteloXosé Bustelo
Xosé Bustelo
Regenerative proliferation capacity and poor differentiation are histological features usually linked to poor prognosis in head and neck squamous cell carcinoma (hnSCC). However, the pathways that regulate them remain ill-characterized. Here, we show that those traits can be triggered by the RHO GTPase activator VAV2 in keratinocytes present in the skin and oral mucosa. VAV2 is also required to maintain those traits in hnSCC patient-derived cells. This function, which is both catalysis- and RHO GTPase-dependent, is mediated by c-Myc- and YAP/TAZ-dependent transcriptomal programs associated with regenerative proliferation and cell undifferentiation, respectively. High levels of VAV2 transcripts and VAV2-regulated gene signatures are both associated with poor hnSCC patient prognosis. These results unveil a druggable pathway linked to the malignancy of specific SCC subtypes.

17 May 2006 in Cell Division
Verified
Journal Article
Open access
PDF file
MCMyriam Cuadrado
Myriam Cuadrado
BMBarbara Martinez-Pastor
Barbara Martinez-Pastor
OFOscar Fernandez-Capetillo
Oscar Fernandez-Capetillo
Unrepaired DNA double-strand breaks (DSBs) are a major cause for genomic instability. Therefore, upon detection of a DSB a rapid response must be assembled to coordinate the proper repair/signaling of the lesion or the elimination of cells with unsustainable amounts of DNA damage. Three members of the PIKK family of protein kinases -ATM, ATR and DNA-PKcs- take the lead and initiate the signaling cascade emanating from DSB sites. Whereas DNA-PKcs activity seems to be restricted to the phosphorylation of targets involved in DNA repair, ATM and ATR phosphorylate a broad spectrum of cell cycle regulators and DNA repair proteins. In the canonical model, ATM and ATR are activated by two different types of lesions and signal through two independent and alternate pathways. Specifically, ATR is activated by various forms of DNA damage, including DSBs, arising at stalled replication forks ("replication stress"), and ATM is responsible for the signaling of DSBs that are not associated with the replication machinery throughout the cell cycle. Recent evidence suggests that this model might be oversimplified and that coordinated crosstalk between ATM and ATR activation routes goes on at the core of the DNA damage response.

1 June 2018 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
GHGeorg Hilfenhaus
Georg Hilfenhaus
DNDai Phuong Nguyen
Dai Phuong Nguyen
JFJonathan Freshman
Jonathan Freshman
DPDivya Prajapati
Divya Prajapati
FMFeiyang Ma
Feiyang Ma
MIM. Luisa Iruela-Arispe
M. Luisa Iruela-Arispe
Through multiple cell–cell and cell–matrix interactions, epithelial and endothelial sheets form tight barriers. Modulators of the cytoskeleton contribute to barrier stability and act as rheostats of vascular permeability. In this study, we sought to identify cytoskeletal regulators that underlie barrier diversity across vessels. To achieve this, we correlated functional and structural barrier features to gene expression of endothelial cells (ECs) derived from different vascular beds. Within a subset of identified candidates, we found that the guanosine nucleotide exchange factor Vav3 was exclusively expressed by microvascular ECs and was closely associated with a high-resistance barrier phenotype. Ectopic expression of Vav3 in large artery and brain ECs significantly enhanced barrier resistance and cortical rearrangement of the actin cytoskeleton. Mechanistically, we found that the barrier effect of Vav3 is dependent on its Dbl homology domain and downstream activation of Rap1. Importantly, inactivation of Vav3 in vivo resulted in increased vascular leakage, highlighting its function as a key regulator of barrier stability.